CClinicalTrials.gg
CompletedNCT04200196PEDIPAINUpdated Feb 24, 2025

Improvement of Anxiety Management During a Venous Puncture About Children with a Participatory Entertainment Method

An interventional study of "fabrique à histoire" and Usual care in Anxiety Disorders, sponsored by University Hospital, Brest. Completed at 1 site in France. Open to participants aged 3 Years to 6 Years. Per ClinicalTrials.gov, last updated 2025-02-24.

Sponsored by University Hospital, Brest · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
116
Allocation
Not applicable
Ages
3 Years to 6 Years
Sex
All
01

Study summary

The purpose of this study is to demonstrate an anxiety decrease about children 3 to 6 years during a venous puncture with the "fabrique à histoire".

Read the detailed description

The purpose of this study is to demonstrate an anxiety decrease about children 3 to 6 years during a venous puncture with the "fabrique à histoire".

the study will compare the "fabrique à histoire"(Lunii(R)) with the usual care.

02

Conditions studied

  • Anxiety Disorders

Browse trials for

Keywords

  • anxiety
  • children
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 116 is above the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

University Hospital, Brest is the lead sponsor of 594 studies on the registry; 135 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 6 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Children 3 to 6 years in pediatric emergency needing to venous puncture
  • Oral consent by children
  • Informed and signed consent by tenured of parent authority
  • To have Anaesthetic patch 45 minutes or more before the venous puncture

Exclusion criteria

Exclusion Criteria:

  • To have Anaesthetic patch less than 45 minutes before the venous puncture because of necessity to blood test or an other emergency
  • Necessity to analgesic 3 emergency
  • Necessity to MEOPA
  • Minor parents
  • Assessment of anxiety is not possible because of comorbidity
  • Anterior participation to these study
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
116 participants (actual)

Study arms

  • Experimental
    "Fabrique à histoire"

    Children 3 to 6 years in pediatric emergency needing to venous puncture and randomized in the "fabrique à histoire (Lunii(R))" arm in addition to the routine anaesthetic cream patch.

    Procedure: "fabrique à histoire"

  • Active comparator
    Usual care

    Children 3 to 6 years in pediatric emergency needing to venous puncture and randomized in the habitual care arm in addition to the routine anaesthetic cream patch.

    Procedure: Usual care

Interventions

  • Procedure"fabrique à histoire"

    "Fabrique à histoire" is a participatory entertainment method. Children of this arm going to create and listening a story before and during the venous puncture.

  • ProcedureUsual care

    It is a passive entertainment method. Children of this arm going to do habitual activities before and during the venous puncture, like to sing, blow up a balloon, to play with recreational thing, etc.

06

What researchers measure

Primary outcomes

  1. modified Yale Preoperative Anxiety Scale (mYPAS)

    Evolution of mYPAS (validated anxiety scale with a scale 23,3 (no anxiety) to 100 (max of anxiety) between T0 (before venipuncture) and T1 (venipuncture). mYPAS is quoted by an extern observator

    Time frame: During venipuncture, an average of 1,5 hours

  2. modified Yale Preoperative Anxiety Scale (mYPAS)

    Evolution of mYPAS (validated anxiety scale with a scale 23,3 (no anxiety) to 100 (max of anxiety) between T0 and T2 (after venipuncture). mYPAS is quoted by an extern observator.

    Time frame: through study completion, an average of 2 hours

Secondary outcomes

  1. Children face scale

    Evolution of Self-assessment of pain with the face scale caused by the venous puncture for children 4 to 6 years between T0 and T2 (after venipuncture)

    Time frame: through study completion, an average of 2 hours

  2. FLACC Scale

    Evolution assessment of pain caused by the venous puncture for children assess by caregivers and measured with FLACC Scale (Face Legs Activity Cry Consolability / 0=no pain and 10=max pain) between T0 and T2 (after venipuncture)

    Time frame: through study completion, an average of 2 hours

  3. Parent anxiety assessment

    Assessment of anxiety caused by the venous puncture for children assess by parents at T2 with an Analogue and Visual Scale (AVS) 10 levels (0=No anxiety 10=max anxiety)

    Time frame: through study completion, an average of 2 hours

  4. Parent pain assessment

    Assessment of pain caused by the venous puncture for children assess by parents at T2 with an AVS 10 level (0=No pain 10=max pain)

    Time frame: through study completion, an average of 2 hours

  5. Number of venous puncture before success

    Number of venous puncture tentative(s) before success

    Time frame: through study completion, an average of 2 hours

  6. Venous puncture success

    Success or not (Yes/No) of the venous puncture

    Time frame: through study completion, an average of 2 hours

  7. Time before venous puncture success

    Measure of time spent performing the act before its success

    Time frame: through study completion, an average of 2 hours

  8. Caregivers feedback

    Assessment of caregivers feedback from the gesture with an AVS 0 (worst feeling) to 10 (best feeling)

    Time frame: through study completion, an average of 2 hours

  9. Parents feedback

    Assessment of parents feedback from the gesture with an AVS 0 (worst feeling) to 10 (best feeling)

    Time frame: through study completion, an average of 2 hours

07

Study locations

1 site
  • CHRU de Brest
    Brest, Finistère 29200, France
08

References and documents

Individual participant data

Plan to share: Yes — All collected data that underlie results in a publication

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04200196
Lead sponsor
University Hospital, Brest
Responsible party
Sponsor
First posted
Dec 16, 2019
Start date
Jun 25, 2020
Primary completion
Aug 5, 2024
Completion
Aug 5, 2024
Last update
Feb 24, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion